Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated balance sheets

v3.23.1
Consolidated balance sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 77,810 $ 128,879
Restricted deposits 9,814 11,474
Accounts receivable, net 38,141 31,017
Deferred contract costs 9,789 8,470
Prepaid expenses and other current assets 6,628 7,847
Total current assets 142,182 187,687
Property and equipment, net 31,823 6,356
Deferred contract costs, non-current 8,348 9,208
Operating lease right-of-use assets 40,823 0
Intangible assets, net 9,561 11,617
Goodwill 12,867 11,318
Other non-current assets 441 813
Total assets 246,045 226,999
Current liabilities:    
Borrowings under Credit Facility 25,000 0
Accounts payable 7,144 11,303
Payroll and benefit related liabilities 18,512 17,969
Deferred revenue 93,195 76,676
Other payables and accrued expenses 27,990 28,199
Operating lease liabilities 9,091 0
Total current liabilities 180,932 134,147
Deferred revenue, non-current 974 2,074
Operating lease liabilities, non-current 40,075 0
Deferred rent 0 2,602
Other long-term liabilities 2,113 3,262
Total liabilities 224,094 142,085
Commitments and contingencies (Note 16)
Shareholders' equity    
Ordinary Shares, NIS 0.01 par value 500,000,000 and 500,000,000 shares authorized as of December 31, 2021 and 2022, respectively; 74,847,609 and 76,435,940 shares issued as of December 31, 2021 and 2022, respectively; 74,845,441 and 76,433,772 shares outstanding as of December 31, 2021 and 2022, respectively; 210 205
Additional paid-in capital 345,834 324,614
Accumulated other comprehensive income (loss) (367) 160
Accumulated deficit (323,726) (240,065)
Total shareholders' equity 21,951 84,914
Total liabilities and shareholders' equity $ 246,045 $ 226,999